Trending Content - Investment Banking Forum
| +185 | Evercore > Goldman and I don’t think it’s particularly close anymore | 65 | 4h |
| +157 | Article: Why UBS's Asian M&A bankers are thriving and UBS's American M&A bankers are not | 17 | 1d |
| +87 | UBS Offer Day | 30 | 1d |
| +86 | Santander IB? | 10 | 3d |
| +71 | I hate Wells Fargo | 19 | 1d |
| +67 | Think Twice before Recruiting for HOUSTON IB!! | 36 | 1h |
| +51 | No return offer - feeling like a failure is an understatement | 20 | 19h |
| +48 | How cooked am I as an incoming WF IB SA 2027? | 17 | 16h |
| +46 | WF Return offers | 28 | 2d |
| +40 | 2026 Investment Banking Return Offer Climate | 25 | 1d |
Career Resources
No. Hope this helps😊
.
If you have to ask......
I think its pretty simple. You look at compensation and exits. Guggenheim is a top tier firm in both categories so I do not think it is ridiculous to call them an EB
Do top tier firms significantly overestimate the amount of deal flow to the point where they have to cut half their intern class + analysts?
This just never happened
It's probably on PWP's tier more or less
RX yes elsewhere no
Recently left Guggenheim after 2 years and I wouldn't classify it as an EB. My analyst class had close to 100 analysts across all offices, which for reference is around Evercore's class size with a fraction of their deal flow. Aggressive hiring has not exactly worked out, and there have been recent layoffs in key groups (NY TMT, Chicago office). If you place into a good group you can still exit well, but the firm as a whole has not performed that well in the past 1-2 years.
Their RX team is EB level, M&A team honestly depends on the group (healthcare and TMT are pretty good, other groups not so much)
How is their Healthcare group? I know they are close advisor to Pfizer, but apart from that?
.
nope. Also, I think a boutique named PEI global just poached a lot of their power/renewables team. I know an associate/analyst and the VP of their power team left for PEI a month or two ago.
Their RX team has been doing very well, especially with Homer Parkhill who’s helped position them to be stronger than his former team at Rothschild (2018+) by quite a bit. Think their fee on Rite Aid was insanely high too.
They’re still a cut below the Restructuring platforms at PJT, Evercore, Lazard, HL but are on an upward trend.
Judging by quality of mandates over the past 2 years + quality of seniors, GUGG RX > LAZ RX
Would agree that Gugg is on an upward trend in RX while Lazard's RX mandate quality has been going down.
To be honest, within banking, it carries the same respect as any other EB as far as recruiting for other banks. Comp is also top, idk why, but comp was just very solid somehow. Guggenheim has opened a lot of doors for me, people were generally nice, one or two complete A-holes. Deal flow did suck honestly but when there were deals, they were big. Depends on what you're looking for overall. It's a slight cut below EB but overall is a great shop and a lot of back and forth with other EB's in terms of talent and key players.
Autem et expedita nulla dolor deleniti. Sit dolorem numquam nam sunt cupiditate similique magni voluptatem. Dignissimos minima architecto quae minus eos veniam accusantium. A ea ducimus eaque itaque eos omnis.
Recusandae amet voluptas dolorum rerum quis rem. Id omnis fugit assumenda amet. Voluptatem iure corporis quam laborum iste est. Est qui aut magni tenetur aut.
Quia et non esse esse dicta. Omnis sint sed aspernatur temporibus. Rerum velit non nobis ea.
Quae numquam eos praesentium autem. Quo quia officia dignissimos sapiente nobis. Qui occaecati culpa molestiae et quo rerum at totam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...